Skip to main content
OpenTrials
Completed

NCT Number: NCT00585715

Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening

The purpose of this research study is to evaluate effectiveness of a non-ablative (does not remove skin) treatment for cellulite (dimpled fat) in conjunction with skin tightening using the Candela GentleYAG laser.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beckman Laser Institute, Irvine, California, United States

Loading trial locations.

About this study

The objective of this investigation is to evaluate the effectiveness of a non-ablative treatment for skin laxity by increasing dermatofibrosis of the reticular dermis using the Candela GentleYAG laser. Treatment areas will be limited to the thighs.

  • The primary objective is to assess the safety and efficacy of the laser for improvement in appearance of cellulite.
  • The secondary objective is to assess the safety and efficacy of the laser with cooling and the laser without cooling for improvement in appearance of cellulite.

This is an open label trial. Treatment will be conducted on either the left or the right thigh, which will be randomly determined. The contra-lateral side will not be treated and will serve as a control. A comparison of baseline photographs (prior to treatments) to photographs taken 1 and 3 months after the completion of treatments will be conducted. Photographic equipment and the protocol for photography will be consistent at each visit. Ultrasound may be taken at baseline and at the follow-up visits to evaluate flatness of cellulite and dermal fibrosis or enlargement of the reticular dermis. The circumference of the area to be treated will be measured with a tape measure, weight/height will be recorded and the Body Mass Index (BMI) will be calculated at baseline and follow-up visits. In addition, skin elasticity may be measured at the treatment areas at baseline and follow-up visits. The photographs, ultrasound and measurements will be taken using consistent procedures at each visit by viewing the baseline photograph and using landmarks such as freckles and birthmarks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals, male or female, greater than 40 years of age.
  • Moderate skin laxity in the arms, legs, abdomen, or neck.
  • Subject is not overweight. Body Mass Index (B.M.I.) is ≤ 27.
  • Subject has Fitzpatrick skin phototype I-IV.
  • Subject is willing to participate in study and adhere to follow-up schedule.
  • Subject is able to read and comprehend English.
  • Subject has completed Informed Consent Form.

Exclusion criteria

  • Subjects that have had liposuction or other surgical procedures (including mesotherapy) to remove fat in the treatment area during the past year.
  • Subject is overweight (BMI > 27).
  • Subject has known photosensitivity or history of ingesting medications known to induce photosensitivity in the previous 3 months.
  • Subject has a personal or family history of keloid formation or scarring.
  • Subject is pregnant or lactating.
  • Subject has a history of uncontrolled diabetes and/or requires medication which may interfere with the study.
  • Subjects with a known history of neuropathy.
  • Subjects with a known history of a coagulopathy.
  • Subject is unable or unwilling to comply with the study requirements
  • Subject has pacemaker or metallic implants.
  • Subject has Fitzpatrick skin type V and VI.
  • Subject is mentally incompetent or a prisoner.

Treatment and study plan

1064 nm Nd:YAG laser

Device

3 treatments at 3-5 week intervals Spot size: 10 - 18 mm diameter Fluence: 50 J/cm2 Laser pulse duration: 50 ms Rep. rate: Up to 2 Hz DCD cooling 0-50 ms

Other names: Candela Gentle YAG Laser

Primary outcomes

  1. Number of Participants With Mild to Moderate Reduction in Cellulite.

    Time frame: 6 month follow up

    Nurnberger-Muller Scale :

    Stage 0: No dimpling. Stage 1: No dimpling. Stage 2: Dimpling spontaneously standing. Stage 3: Dimpling spontaneously standing and lying down.

    Texture Scale:

    Hard or Solid: Pinch test "firm folds and furrows." Adherent to deep planes. Not modified with lying versus standing position.

    Soft or Flaccid: Pinch test "spongy and floating folds and furrows." No adherence to deep planes. Not painful, flaccid. "Orange peel skin" appears spontaneously.

    Edematous: Doughy consistency. Pain and cramps. Signs of venous and lymphatic insufficiency "legs in boot/column".

    At the 6month follow-up, a blinded assessor ranked changes in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as "no change" and 3 as "significant change." Improvement in cellulite appearance was characterized by an increase of one unit or more on this scale.

  2. Average Extent of Reduction in Cellulite Appearance for Patients With Reported Mild to Moderate Cellulite Reduction.

    Time frame: 6 month follow up

    At the 6 month follow-up, a blinded assessor ranked change in cellulite appearance on subject's thighs according to the prior cellulite dimpling and texture criteria. Change in cellulite appearance was assessed on a scale of 0-3, with 0 as "no change" and 3 as "significant change."

    Using this scale, the average reduction in cellulite appearance was calculated for each participant that experienced a mild to moderate reduction in cellulite appearance.

Sponsors and collaborators

Lead sponsor

University of California, Irvine

Other

Collaborators

  • Candela Corporation

Registry information

Acronym: IH062905

Important dates

Study start
2006
Primary completion
2009
Study completion
2010
First posted
Jan 3, 2008
Registry last updated
Oct 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.